Headline
The latest stories from AHA Today.
The Food and Drug Administration Oct. 15 removed epinephrine from the lists of drugs authorized for temporary compounding during the COVID-19 public health emergency by outsourcing facilities and state-licensed pharmacies or federal facilities not registered as outsourcing facilities.
The Food and Drug Administration Oct. 15 said it reissued its emergency use authorization for certain, Chinese-manufactured filtering face-piece respirators that lack National Institute for Occupational Safety and Health approval.
The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.
The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.
The AHA Oct. 21 at noon ET will host a webinar featuring leaders from Henry Ford Health System, Ascension Wisconsin and Loyola University Chicago’s Stritch School of Medicine discussing their approaches to addressing community and population health as the field moves from pandemic response to…
The AHA’s American Society for Health Care Engineering Oct. 7 awarded its 2020 Energy Champion Award for outstanding leadership in energy efficiency to The Atrium Health Cleveland in Shelby, N.C.
A federal appeals court in Washington, D.C., heard oral argument in an appeal from the AHA and hospital groups to overturn a Department of Health and Human Services rule requiring hospitals to disclose their confidential privately negotiated charges with insurers.
A new study published Oct. 14 in JAMA Cardiology is highlighting flaws in the Centers for Medicare & Medicaid Services’ Hospital Readmission Reduction Program that resulted in inappropriate penalties on hospitals or, in some cases, overlooking hospitals that should have been penalized.
In part three of a Value Rounds series on working toward value together, leaders from Northwell Health and Atrium Health's Carolinas Medical Center discuss the role of health care providers — from the front lines to leadership — in improving outcomes, enhancing the patient experience and reducing…
The Food and Drug Administration Oct. 14 approved Inmazeb for treating Zaire ebolavirus infection in adult and pediatric patients.